Defining molecular mechanisms in the SLC26 family of proteins
Defining molecular mechanisms in the SLC26 family of proteins
批准号:
9246526
负责人:
Kazuaki Homma
金额:
$15.45万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2018-06-30
关键词:
AffectAmino Acid SequenceAnimalsAnionsBicarbonatesBiologicalBiological AssayCell LineDataDevelopmentDiseaseElectric CapacitanceElectrophysiology (science)FamilyFamily memberFrequenciesFutureGene FamilyGenesGoalsHearingHumanImpairmentIn VitroIon TransportKineticsKnowledgeMammalsMapsMeasurementMediatingMembraneMethodsMissense MutationModelingMolecularMotorMotor ActivityMutateMutationOutcomeOuter Hair CellsPathologyPathway interactionsPatientsPhysiologicalProtein FamilyProteinsProtocols documentationRecombinant ProteinsReportingResearchStimulusStructural ModelsStructureSyndromeSystemTestingTherapeuticbasedesigndisease phenotypedisease-causing mutationexperimental studyhearing impairmenthuman diseaseinsightmembermutantoperationprotein functionpublic health relevancerat Pres proteinslow potentialsolutevoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Numerous mutations that are associated with both syndromic and non-syndromic hearing impairment have been found in pendrin and prestin, which are members of the SLC26 family. In most cases, it is not clear how these mutations disrupt the normal function of pendrin and prestin proteins. Characterization of such disease- associated mutations in human patients is, therefore, urgently needed to understand the underlying pathology. Data collected in these experiments will further our understanding of the molecular mechanisms of normal pendrin and prestin on their transport and motor functions. Using this information, we will develop mechanistic models of the proteins, which are expected to generalize to all other SLC26-family members, and could be exploited to develop remedies against disease-causing mutations found in the SLC26 family of proteins in the future. Aims 1 and 2 are designed to determine the effects of disease-associated missense mutations reported for pendrin (Aim 1) and prestin (Aim 2) on their anion transport and voltage-dependent motor functions using recombinant proteins heterologously expressed in cell lines. Aim 3 will develop mechanistic models that explain transport (pendrin) and motor (prestin) functions based on the results obtained in the preceding Aims. In addition, we will carry out electrophysiological measurements to dissect the kinetics of prestin's motor activity. Standard molecular biological methods will be used to generate mutated protein constructs whose functional assessment will be performed using cell lines (in vitro). Animals will not be used in this study. Taken together, the proposed research will not only fill the gap between our current knowledge of disease-associated mutations and their functional consequences, but also help elucidate detailed molecular mechanisms of SLC26 family of proteins.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1074/jbc.ra118.001831
发表时间:
2018-06-29
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Kuwabara, Makoto F., Wasano, Koichiro, Homma, Kazuaki]
通讯作者:
Homma, Kazuaki
Defining the pathological mechanisms of hereditary hearing loss
-
批准号:10529295
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2018
-
负责人:Kazuaki Homma
-
依托单位:
Defining the pathological mechanisms of hereditary hearing loss
-
批准号:10058834
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2018
-
负责人:Kazuaki Homma
-
依托单位:
Defining the pathological mechanisms of hereditary hearing loss
-
批准号:10303026
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2018
-
负责人:Kazuaki Homma
-
依托单位:
海外基金